INSIDE: Intervention in Nutritional Supplementation to Improve Cognitive Decline in Elderly.
INSIDE
INSIDE: Intervenção da Suplementação Nutricional na Melhoria do Declínio Cognitivo no Idoso.
1 other identifier
interventional
50
1 country
1
Brief Summary
This study investigates the effect of nutritional supplementation on cognitive performance in older adults over a 90-day period using a double-blind randomized controlled design. The study includes 50 participants, aged 65 or older, randomly assigned to either a supplement group or a placebo group. Participants will be randomly assigned to either the experimental or control group. Assessments will be conducted pre- and post-intervention to determine the effect of the supplementation on cognitive performance. Key outcomes include cognitive status measured by MoCA, adherence to supplementation, and potential side effects. The findings will provide insights into the potential role of nutritional interventions in mitigating age-related cognitive decline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2025
CompletedFirst Submitted
Initial submission to the registry
May 24, 2025
CompletedFirst Posted
Study publicly available on registry
June 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2025
CompletedJune 3, 2025
May 1, 2025
5 months
May 24, 2025
May 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognitive Performance
Change in cognitive performance measured by MoCA before and after intervention (90 days)
baseline and 90 days
Secondary Outcomes (5)
Adherence to supplementation protocol
Daily, from Day 1 to Day 90
Occurrence of adverse effects
Continuous, from baseline to Day 90
Self-reported use of other supplements
Baseline and 90 days
Self-perceived quality of life
baseline and 90 days
Depressive symptoms
Baseline and Day 90
Study Arms (2)
Nutritional Supplement
EXPERIMENTALParticipants in this arm will receive a daily dose of a nutritional supplement for 90 consecutive days. The supplement is administered orally and aims to improve cognitive performance in older adults with signs of cognitive decline. Participants will also complete cognitive assessments before and after the intervention.
Placebo
PLACEBO COMPARATORParticipants in this arm will receive a daily dose of an inert placebo that matches the supplement in appearance, taken orally for 90 consecutive days. The placebo is used as a control to compare the effects of the nutritional supplement on cognitive performance. Participants will undergo the same cognitive assessments as the experimental group.
Interventions
Participants in this arm will receive a daily dose of a nutritional supplement for 90 consecutive days. The supplement is administered orally and aims to improve cognitive performance in older adults with signs of cognitive decline. Participants will also complete cognitive assessments before and after the intervention.
Participants in this arm will receive a daily dose of an inert placebo that matches the supplement in appearance, taken orally for 90 consecutive days. The placebo is used as a control to compare the effects of the nutritional supplement on cognitive performance. Participants will undergo the same cognitive assessments as the experimental group.
Eligibility Criteria
You may qualify if:
- Community-dwelling adults aged 65 years or older Evidence of mild cognitive decline (score \< 26 on the Montreal Cognitive Assessment - MoCA) Ability to provide written informed consent Willingness and ability to comply with study procedures and attend scheduled evaluations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maria Paçolead
Study Sites (1)
Escola Superior de Saúde do Vale do Ave
Vila Nova de Famalicão, Braga District, 4760-409, Portugal
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
May 24, 2025
First Posted
June 3, 2025
Study Start
April 20, 2025
Primary Completion
September 20, 2025
Study Completion
November 20, 2025
Last Updated
June 3, 2025
Record last verified: 2025-05